XTL Biopharmaceuticals Ltd ADR Cash Flow-to-Debt Ratio
XTL Biopharmaceuticals Ltd ADR cash flow-to-debt ratio. XTL Biopharmaceuticals Ltd ADR (XTLB) has a Cash Flow-to-Debt Ratio of -10.73x as of December 2022, meaning its operating cash flow of $-2.01 Million could theoretically repay -11% of its total liabilities ($187.00K) in one year. Check earnings quality score of XTL Biopharmaceuticals Ltd ADR to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of XTL Biopharmaceuticals Ltd ADR (2003–2025)
Cash flow-to-debt ratio of XTL Biopharmaceuticals Ltd ADR from 2003 to 2025. Historical debt coverage capacity for XTL Biopharmaceuticals Ltd ADR across 23 annual periods. Check XTLB total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
XTL Biopharmaceuticals Ltd ADR Cash Flow-to-Debt Ratio by Year (2003–2025)
XTL Biopharmaceuticals Ltd ADR cash flow-to-debt ratio by year from 2003 to 2025. Year-by-year debt coverage analysis for XTL Biopharmaceuticals Ltd ADR. For the full cash flow conversion analysis, see cash efficiency ratio of XTL Biopharmaceuticals Ltd ADR.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.44x | $-1.02 Million | $420.00K | ▼ -369.8% |
| 2024 | -0.52x | $-1.62 Million | $3.12 Million | ▲ +84.9% |
| 2023 | -3.43x | $-707.00K | $206.00K | ▲ +28.8% |
| 2022 | -4.82x | $-901.00K | $187.00K | ▼ -490.2% |
| 2021 | -0.82x | $-1.05 Million | $1.28 Million | ▲ +75.6% |
| 2020 | -3.35x | $-850.00K | $254.00K | ▲ +14.5% |
| 2019 | -3.91x | $-908.00K | $232.00K | ▼ -21.3% |
| 2018 | -3.23x | $-816.00K | $253.00K | ▼ -750.6% |
| 2017 | -0.38x | $-1.12 Million | $2.97 Million | ▲ +92.8% |
| 2016 | -5.25x | $-1.73 Million | $330.00K | ▼ -23.0% |
| 2015 | -4.27x | $-1.86 Million | $436.00K | ▼ -66.8% |
| 2014 | -2.56x | $-2.47 Million | $965.00K | ▼ -26.0% |
| 2013 | -2.03x | $-2.50 Million | $1.23 Million | ▼ -124.2% |
| 2012 | -0.91x | $-1.51 Million | $1.66 Million | ▲ +68.4% |
| 2011 | -2.86x | $-1.80 Million | $629.00K | ▼ -275.1% |
| 2010 | -0.76x | $-735.00K | $963.00K | ▲ +78.3% |
| 2009 | -3.51x | $-2.49 Million | $708.00K | ▲ +33.4% |
| 2008 | -5.28x | $-10.58 Million | $2.00 Million | ▼ -36.9% |
| 2007 | -3.86x | $-21.46 Million | $5.56 Million | ▼ -26.9% |
| 2006 | -3.04x | $-12.59 Million | $4.14 Million | ▼ -13.3% |
| 2005 | -2.68x | $-10.47 Million | $3.90 Million | ▼ -11.5% |
| 2004 | -2.41x | $-14.49 Million | $6.02 Million | ▲ +23.3% |
| 2003 | -3.14x | $-13.33 Million | $4.25 Million | — |